Cargando…

GA-OH enhances the cytotoxicity of photon and proton radiation in HPV(+) HNSCC cells

INTRODUCTION: Treatment-related toxicity following either chemo- or radiotherapy can create significant clinical challenges for HNSCC cancer patients, particularly those with HPV-associated oropharyngeal squamous cell carcinoma. Identifying and characterizing targeted therapy agents that enhance the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chitsike, Lennox, Bertucci, Antonella, Vazquez, Marcelo, Lee, Steve, Unternaehrer, Juli J., Duerksen-Hughes, Penelope J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950506/ https://www.ncbi.nlm.nih.gov/pubmed/36845698 http://dx.doi.org/10.3389/fonc.2023.1070485

Ejemplares similares

Targeted Therapy as a Potential De-Escalation Strategy in Locally Advanced HPV-Associated Oropharyngeal Cancer: A Literature Review
por: Chitsike, Lennox, et al.
Publicado: (2021)

Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
por: Chitsike, Lennox, et al.
Publicado: (2021)

PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6
por: Chitsike, Lennox, et al.
Publicado: (2021)

A high-content AlphaScreen™ identifies E6-specific small molecule inhibitors as potential therapeutics for HPV(+) head and neck squamous cell carcinomas
por: Chitsike, Lennox, et al.
Publicado: (2021)

ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics
por: Chitsike, Lennox, et al.
Publicado: (2021)

Proton-induced DNA damage promotes integration of foreign plasmid DNA into human genome
por: Katerji, Meghri, et al.
Publicado: (2022)

The Impact of YRNAs on HNSCC and HPV Infection
por: Guglas, Kacper, et al.
Publicado: (2023)

Modulation of Apoptotic Pathways by Human Papillomaviruses (HPV): Mechanisms and Implications for Therapy
por: Yuan, Chung-Hsiang, et al.
Publicado: (2012)

Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer
por: Whang, Sonia N., et al.
Publicado: (2015)

Roscovitine strongly enhances the effect of olaparib on radiosensitivity for HPV neg. but not for HPV pos. HNSCC cell lines
por: Ziemann, Frank, et al.
Publicado: (2017)

Selenium Attenuates HPV-18 Associated Apoptosis in Embryo-Derived Trophoblastic Cells but Not Inner Cell Mass In Vitro
por: Tolen, Jennifer A., et al.
Publicado: (2015)

Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines
por: Busch, Chia-Jung, et al.
Publicado: (2016)

Cyclin A1 shows age-related expression in benign tonsils, HPV16-dependent overexpression in HNSCC and predicts lower recurrence rate in HNSCC independently of HPV16
por: Weiss, Daniel, et al.
Publicado: (2012)

IL1 Pathway in HPV-Negative HNSCC Cells Is an Indicator of Radioresistance After Photon and Carbon Ion Irradiation Without Functional Involvement
por: Tiwari, Dinesh Kumar, et al.
Publicado: (2022)

HPV-16 infection modifies overall survival of Puerto Rican HNSCC patients
por: Rivera-Peña, Bianca, et al.
Publicado: (2016)

mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC
por: Coppock, Joseph D., et al.
Publicado: (2016)

Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort
por: Qin, Tingting, et al.
Publicado: (2018)

HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patients
por: Burr, Adam R, et al.
Publicado: (2018)

CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
por: Paulsen, Finn-Ole, et al.
Publicado: (2020)

Flavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV(+) cells
por: Yuan, C-H, et al.
Publicado: (2016)

FcGBP was upregulated by HPV infection and correlated to longer survival time of HNSCC patients
por: Wang, Yating, et al.
Publicado: (2017)

Enhancer RNA Profiling in Smoking and HPV Associated HNSCC Reveals Associations to Key Oncogenes
por: Shende, Neil, et al.
Publicado: (2021)

CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(−) HNSCC Cell Lines
por: Trembley, Janeen H., et al.
Publicado: (2021)

Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line
por: Harris, Matthew, et al.
Publicado: (2011)

HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC
por: Zeng, Hao, et al.
Publicado: (2020)

HPV Enhances HNSCC Chemosensitization by Inhibiting SERPINB3 Expression to Disrupt the Fanconi Anemia Pathway
por: Huang, Zixian, et al.
Publicado: (2022)

Current landscape of clinical trials for HPV-positive head and neck squamous cell carcinoma (HNSCC)
por: Bteich, Yara T, et al.
Publicado: (2022)

Cellular binding partners of the human papillomavirus E6 protein
por: Tungteakkhun, Sandy S., et al.
Publicado: (2008)

Preferential Activation of the Hedgehog Pathway by Epigenetic Modulations in HPV Negative HNSCC Identified with Meta-Pathway Analysis
por: Fertig, Elana J., et al.
Publicado: (2013)

β(2)-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC
por: Lucido, Christopher T., et al.
Publicado: (2018)

Fewer tumour-specific PD-1(+)CD8(+) TILs in high-risk “Infiltrating” HPV(−) HNSCC
por: Xu, Ke, et al.
Publicado: (2020)

Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC
por: Gui, Shanying, et al.
Publicado: (2021)

The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate‐risk HPV‐negative HNSCC
por: Tasoulas, Jason, et al.
Publicado: (2021)

PIK3CA Gene Mutations in HNSCC: Systematic Review and Correlations with HPV Status and Patient Survival
por: Cochicho, Daniela, et al.
Publicado: (2022)

Deciphering the role of HPV-mediated metabolic regulation in shaping the tumor microenvironment and its implications for immunotherapy in HNSCC
por: Gong, Xiangjin, et al.
Publicado: (2023)

Approaches and Methods to Measure Oxidative Stress in Clinical Samples: Research Applications in the Cancer Field
por: Katerji, Meghri, et al.
Publicado: (2019)

In HPV-Positive HNSCC Cells, Functional Restoration of the p53/p21 Pathway by Proteasome Inhibitor Bortezomib Does Not Affect Radio- or Chemosensitivity()()
por: Seltzsam, Steve, et al.
Publicado: (2018)

IGF1R and Src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK
por: Lehman, Christine E., et al.
Publicado: (2021)

Incidence and survival of HNSCC patients living with HIV compared with HIV-negative HNSCC patients
por: Haase, Katharina, et al.
Publicado: (2021)

The TP53 Codon 72 Arginine Polymorphism Is Found with Increased TP53 Somatic Mutations in HPV(−) and in an Increased Percentage among HPV(+) Norwegian HNSCC Patients
por: Moe, Svein Erik, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jj4i88kagps4fgtifstcuign00